Skip to Navigation Skip to Search Skip to Content
Search All Centers

What Is the Course for Treatment If Lung Cancer Spreads?

Read Transcript Download/Print Transcript

Published on February 8, 2019

Leading lung cancer expert Dr. Jhanelle Gray, from the Moffitt Cancer Center, explains how to proceed with care when lung cancer is spreading, what treatment options are available and the ultimate goal of personalized medicine. Can genetic markers help indicate next steps for therapy? Tune in to find out now.  

This is a Patient Empowerment Network program produced by Patient Power, in partnership with Moffitt Cancer Center. We thank AbbVie, Inc., Celgene Corporation, Foundation Medicine, and Novartis for their support.

Featuring

Partners

Moffitt Cancer Center

Sponsors

Patient Empowerment Network

You might also like

Transcript | What Is the Course for Treatment If Lung Cancer Spreads?

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That's how you’ll get care that's most appropriate for you.

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

Andrew Schorr:

So, Dr. Gray, I wanna talk about the spread of cancer. So, Ed talked about how he had this on his liver. But you figured out—you all figured out it came from his lung?

Dr. Gray:                     

His lung. Yes. 

Andrew Schorr:          

Lung cancer can spread. Cancer can spread generally. But here we have people with metastatic cancer who are living longer with some of these approaches.

Dr. Gray:                     

Yes.

Andrew Schorr:          

Radiation, immunotherapy.

Dr. Gray:                     

Therapy.

Andrew Schorr:          

Targeted therapy.

Dr. Gray:                     

Different therapies.

Andrew Schorr:          

So, when you tell somebody, “Mr. Jones, yes, you’re right. Imaging, we see your cancer spread.” That’s not the end of the story.

Dr. Gray:                     

Absolutely not. No. So, what we also look at are these genetic findings, the pathology findings, the markers for the immunotherapy. But at the end of the day what your goal is is to extend life and to add quality of life to patients. And so, as we look at this information, we want to make sure that we’re making the right decisions. And this is the goal ultimately of personalized medicine.  

Yes, your cancer may have spread, but we can give you treatments that are gonna knock down the cancer, get it to shrink down, and to a point that sometimes may become undetectable on the scans. We do think that there are cells still circulating there, but we could still continue to follow you and keep track of the cancer and make sure that you’re—we’re helping you to manage this properly.

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

You might also like